Cannabis and cardiovascular health presents one of the most divided evidence bases in the field — with credible research suggesting both protective and harmful effects depending on cannabinoid, dose, frequency, age, and route of administration.
THC and Acute Cardiovascular Effects
THC causes an immediate, dose-dependent increase in heart rate (tachycardia) of 20–100% above baseline, peaking within 15 minutes of inhalation and lasting 2–3 hours. It also causes initial increases in blood pressure followed by orthostatic hypotension. These acute hemodynamic changes are well-documented and clinically significant for patients with existing cardiovascular disease [1].
Case reports and registry data have linked cannabis use to cannabis-associated arteritis, a rare vasospastic condition, and to Kounis syndrome (allergic coronary artery spasm) in predisposed individuals. A large French pharmacovigilance study found cannabis-associated cardiovascular adverse events disproportionately represented in young patients [2].
CBD's Cardioprotective Potential
CBD presents a markedly different profile. It does not cause tachycardia. Studies in isolated heart preparations and animal models demonstrate that CBD reduces ischemia-reperfusion injury, lowers myocardial inflammation, and may reduce infarct size. A 2010 review in the British Journal of Pharmacology summarized preclinical evidence for CBD as a cardioprotective agent, citing anti-inflammatory, antioxidant, and anti-apoptotic mechanisms [3].
Key Evidence Points
- THC increases heart rate 20–100% above baseline — significant risk for existing cardiovascular disease [1]
- French pharmacovigilance data: cannabis-associated CV adverse events predominantly in young users [2]
- CBD does not cause tachycardia and shows preclinical cardioprotective properties [3]
- CBD reduces ischemia-reperfusion injury in animal models — human RCT data lacking
- Smoking cannabis has additional cardiovascular risks beyond cannabinoids (CO exposure, particulates)
Citations
- Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–2809. PubMed 11401936
- Jouanjus E, Lapeyre-Mestre M, Micallef J. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3(2):e000638. doi:10.1161/JAHA.113.000638
- Walsh SK, Hepburn CY, Kane KA, Wainwright CL. Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias. Br J Pharmacol. 2010;160(5):1234–1242. PubMed 20590619